Published in J Cardiovasc Electrophysiol on January 16, 2009
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol (2011) 4.12
Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol (2005) 3.58
Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol (2005) 3.46
Epicardial ventricular tachycardia ablation a multicenter safety study. J Am Coll Cardiol (2010) 2.75
Short QT syndrome: clinical findings and diagnostic-therapeutic implications. Eur Heart J (2006) 2.59
Clinical aspects and prognosis of Brugada syndrome in children. Circulation (2007) 2.29
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21
Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol (2009) 2.20
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Atrial fibrillation ablation using a robotic catheter remote control system: initial human experience and long-term follow-up results. J Am Coll Cardiol (2008) 2.02
"Dormant" pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol (2004) 2.00
Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J (2008) 1.98
Optimizing hemodynamics in heart failure patients by systematic screening of left ventricular pacing sites: the lateral left ventricular wall and the coronary sinus are rarely the best sites. J Am Coll Cardiol (2009) 1.98
Safety and efficacy of cryoablation of accessory pathways adjacent to the normal conduction system. J Cardiovasc Electrophysiol (2003) 1.91
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol (2011) 1.89
The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol (2010) 1.89
Wolff-Parkinson-White ablation after a prior failure: a 7-year multicentre experience. Europace (2010) 1.88
Short QT syndrome: pharmacological treatment. J Am Coll Cardiol (2004) 1.87
Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol (2010) 1.84
Long-term evaluation of atrial fibrillation ablation guided by noninducibility. Heart Rhythm (2006) 1.81
Noninvasive panoramic mapping of human atrial fibrillation mechanisms: a feasibility report. J Cardiovasc Electrophysiol (2013) 1.79
Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol (2009) 1.74
Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study. J Cardiovasc Electrophysiol (2012) 1.72
Validation of novel 3-dimensional electrocardiographic mapping of atrial tachycardias by invasive mapping and ablation: a multicenter study. J Am Coll Cardiol (2013) 1.67
SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet (2009) 1.64
Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation (2006) 1.63
Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol (2006) 1.63
Biventricular stimulation improves right and left ventricular function after tetralogy of Fallot repair: acute animal and clinical studies. Heart Rhythm (2009) 1.58
Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm (2008) 1.56
Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions. Eur Heart J (2007) 1.53
Identification of large families in early repolarization syndrome. J Am Coll Cardiol (2013) 1.50
Postmyocarditis ventricular tachycardia in patients with epicardial-only scar: a specific entity requiring a specific approach. J Cardiovasc Electrophysiol (2014) 1.50
Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol (2002) 1.49
Contributions of a hemodynamic sensor embedded in an atrial lead in a porcine model. J Cardiovasc Electrophysiol (2010) 1.48
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges. Europace (2009) 1.47
A practical criterion for the rapid detection of single-loop and double-loop reentry tachycardias. J Cardiovasc Electrophysiol (2013) 1.45
Microbiologic characteristics and in vitro susceptibility to antimicrobials in a large population of patients with cardiovascular implantable electronic device infection. J Cardiovasc Electrophysiol (2011) 1.42
Additional value of three-dimensional echocardiography in patients with cardiac resynchronization therapy. Arch Cardiovasc Dis (2009) 1.39
Visualizing intramyocardial steam formation with a radiofrequency ablation catheter incorporating near-field ultrasound. J Cardiovasc Electrophysiol (2013) 1.38
Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol (2008) 1.37
Management of subacute and delayed right ventricular perforation with a pacing or an implantable cardioverter-defibrillator lead. Am J Cardiol (2008) 1.25
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Computed tomography-fluoroscopy overlay evaluation during catheter ablation of left atrial arrhythmia. Europace (2008) 1.14
Early recurrences after atrial fibrillation ablation: prognostic value and effect of early reablation. J Cardiovasc Electrophysiol (2008) 1.13
Atrial tachycardia arising adjacent to noncoronary aortic sinus: distinctive atrial activation patterns and anatomic insights. J Am Coll Cardiol (2010) 1.09
Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol (2014) 1.05
Radiation exposure during radiofrequency catheter ablation for atrial fibrillation. Pacing Clin Electrophysiol (2003) 1.05
Dynamicity of the J-wave in idiopathic ventricular fibrillation with a special reference to pause-dependent augmentation of the J-wave. J Am Coll Cardiol (2012) 1.04
Left ventricular endocardial stimulation for severe heart failure. J Am Coll Cardiol (2010) 1.04
Nonpulmonary vein foci: do they exist? Pacing Clin Electrophysiol (2003) 1.02
Spotlight on atrial fibrillation-the 'complete arrhythmia'. Cardiovasc Res (2002) 1.01
ESC-EURObservational Research Programme: the Atrial Fibrillation Ablation Pilot Study, conducted by the European Heart Rhythm Association. Europace (2012) 1.01
Extraction of old pacemaker or cardioverter-defibrillator leads by laser sheath versus femoral approach. Circ Arrhythm Electrophysiol (2010) 0.99
State of the art: catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.98
Dynamic ventricular dyssynchrony: an exercise-echocardiography study. J Am Coll Cardiol (2006) 0.98
Impact of catheter ablation of the coronary sinus on paroxysmal or persistent atrial fibrillation. J Cardiovasc Electrophysiol (2007) 0.97
Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts. J Cardiovasc Electrophysiol (2004) 0.95
Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. Europace (2010) 0.94
Substrate mapping and ablation for ventricular tachycardia: the LAVA approach. J Cardiovasc Electrophysiol (2014) 0.94
Effect of catheter ablation for isolated paroxysmal atrial fibrillation on longitudinal and circumferential left ventricular systolic function. Am J Cardiol (2008) 0.94
Left ventricular endocardial or triventricular pacing to optimize cardiac resynchronization therapy in a chronic canine model of ischemic heart failure. Am J Physiol Heart Circ Physiol (2012) 0.93
Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol (2015) 0.91
Presence of ventricular dyssynchrony and haemodynamic impact of right ventricular pacing in adults with repaired Tetralogy of Fallot and right bundle branch block. Europace (2008) 0.91
An approach to catheter ablation of cavotricuspid isthmus dependent atrial flutter. Indian Pacing Electrophysiol J (2006) 0.91